Related Experiment Video
Updated: Sep 24, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Tenofovir alafenamide fumarate
William A Lee1, Andrew K Cheng2
1San Francisco, CA, USA.
Tenofovir alafenamide fumarate (TAF) offers targeted delivery for HIV treatment, leading to higher drug concentrations in lymphatic tissues. This results in improved bone and kidney health markers compared to older tenofovir disoproxil fumarate (TDF).
Area of Science:
- Pharmacology and Virology
- Drug Metabolism and Delivery
Background:
- Tenofovir alafenamide fumarate (TAF) is a prodrug of tenofovir, designed for targeted intracellular delivery.
- Preferential metabolism in lymphatic tissues leads to high concentrations of tenofovir (TFV) and its active metabolite within cells replicating HIV.
Purpose of the Study:
- To highlight the pharmacokinetic advantages of TAF over tenofovir disoproxil fumarate (TDF).
- To underscore the clinical benefits of TAF, including improved bone and renal biomarkers.
- To establish TAF's role as a foundational component in HIV and HBV therapies.
Main Methods:
- Analysis of TAF's metabolic pathways and tissue distribution.
- Comparison of biomarker data (bone and renal) between TAF and TDF regimens.
- Review of clinical data on TAF in combination therapies and monotherapy.
Main Results:
- TAF achieves high intracellular concentrations of tenofovir diphosphate in HIV-replicating cells.
- TAF administration is associated with superior bone and renal safety profiles compared to TDF.
- TAF is integral to current combination therapies for HIV treatment and pre-exposure prophylaxis (PrEP), and for HBV treatment.
Conclusions:
- TAF's targeted delivery mechanism enhances efficacy and improves safety outcomes.
- TAF represents a significant advancement in antiretroviral therapy and hepatitis B treatment.
- The improved biomarker profile of TAF supports its widespread use in HIV management.
Related Concept Videos
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Subviral Agents
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Retroviruses
Antiepileptic Drugs: Glutamate Antagonists
Antihypertensive Drugs: Direct Renin Inhibitors

